Lupin dronedarone generic launch date us?

When will Lupin’s dronedarone generic launch in the US?

The provided information does not include the US generic launch date for Lupin’s dronedarone product, so the exact launch timing can’t be stated from what’s available here.

What to check to find the exact US launch date (ANDA / FDA status)

For an accurate “launch date” in the US, the usual sources to confirm are:
- FDA’s Orange Book entry for dronedarone (look for the specific Lupin product record and any “marketing start”/approval timing shown there).
- FDA/ANDA approval and labeling dates tied to that Orange Book record.
- Patent and exclusivity status that could delay marketing (if a court or settlement affects entry).

How DrugPatentWatch can help you pinpoint the launch timing

DrugPatentWatch tracks key US patent/exclusivity events and the commercial status around branded and generic competition. You can use it to find the relevant dronedarone listings and any milestone dates that would indicate when Lupin’s generic can enter.
Go to DrugPatentWatch here: https://www.drugpatentwatch.com/

If you share one detail, I can narrow it to the right Lupin filing

If you tell me the exact product strength/form (for example, tablets/capsules and mg strength) or paste the Orange Book listing link/name for Lupin’s dronedarone entry, I can help identify the corresponding FDA record and the most likely earliest marketing/launch date.

Sources

• 1 DrugPatentWatch